Biovica International AB (publ) (STO:BIOVIC.B)
0.3630
-0.0070 (-1.89%)
Jul 3, 2026, 3:54 PM CET
Biovica International AB Balance Sheet
Financials in millions SEK. Fiscal year is May - April.
Millions SEK. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Equivalents | 70.41 | 24.42 | 66.57 | 114.33 | 89.79 |
Short-Term Investments | - | - | 12.84 | - | - |
Cash & Short-Term Investments | 70.41 | 24.42 | 79.41 | 114.33 | 89.79 |
Cash Growth | 188.40% | -69.25% | -30.54% | 27.32% | -38.23% |
Accounts Receivable | 4.72 | 1.82 | 1.67 | 0.58 | 1.13 |
Other Receivables | 0.85 | 0.5 | 1.66 | 0.97 | 0.85 |
Receivables | 5.57 | 2.32 | 3.33 | 1.55 | 1.98 |
Inventory | 2.29 | 1.93 | 2.2 | 1.36 | 1.53 |
Prepaid Expenses | 2.07 | 2.13 | 3.18 | 2.76 | 1.61 |
Other Current Assets | - | -0 | -0 | 0 | - |
Total Current Assets | 80.34 | 30.79 | 88.12 | 119.99 | 94.91 |
Property, Plant & Equipment | 4.42 | 4.77 | 8.11 | 11.21 | 13.64 |
Other Intangible Assets | 0.74 | 1.47 | 2.2 | 2.2 | 3.66 |
Long-Term Deferred Tax Assets | 0.89 | 2.46 | 3.13 | 3.67 | 2.73 |
Long-Term Deferred Charges | 20.98 | 25.06 | 29.4 | 29.4 | 36.69 |
Other Long-Term Assets | 0.38 | 0.4 | 0.45 | 5.82 | - |
Total Assets | 107.75 | 64.95 | 131.41 | 172.29 | 151.63 |
Accounts Payable | 3.13 | 3.54 | 3.03 | 3.28 | 2.89 |
Accrued Expenses | 10.38 | 10.77 | 20.3 | 15.17 | 6.73 |
Current Portion of Leases | 2.55 | 2.92 | 3.53 | 3.15 | 4.46 |
Current Income Taxes Payable | 0.05 | 0.01 | 0.23 | 0.82 | 0.09 |
Other Current Liabilities | 2.6 | 0.91 | 1.2 | 1.22 | 1.93 |
Total Current Liabilities | 18.7 | 18.16 | 28.29 | 23.64 | 16.09 |
Long-Term Leases | 1.75 | 1.74 | 4.3 | 7.3 | 8.78 |
Long-Term Deferred Tax Liabilities | 0.96 | 1.85 | 2.18 | 2.71 | 2.67 |
Other Long-Term Liabilities | - | - | 0 | - | - |
Total Liabilities | 21.42 | 21.74 | 34.77 | 33.65 | 27.54 |
Common Stock | 19.46 | 6.52 | 5.6 | 3.05 | 1.9 |
Additional Paid-In Capital | 678.04 | 577.82 | 543.85 | 463.94 | 340.05 |
Retained Earnings | -610.78 | -540.92 | -453.23 | -328.47 | -217.97 |
Comprehensive Income & Other | -0.39 | -0.22 | 0.41 | 0.12 | 0.11 |
Shareholders' Equity | 86.33 | 43.21 | 96.64 | 138.64 | 124.09 |
Total Liabilities & Equity | 107.75 | 64.95 | 131.41 | 172.29 | 151.63 |
Total Debt | 4.3 | 4.65 | 7.83 | 10.45 | 13.25 |
Net Cash (Debt) | 66.11 | 19.76 | 71.58 | 103.87 | 76.55 |
Net Cash Growth | 234.52% | -72.39% | -31.09% | 35.70% | -46.45% |
Net Cash Per Share | 0.28 | 0.21 | 1.23 | 2.98 | 2.69 |
Filing Date Shares Outstanding | 291.91 | 97.79 | 84.06 | 45.74 | 28.49 |
Total Common Shares Outstanding | 291.91 | 97.79 | 84.06 | 45.74 | 28.49 |
Working Capital | 61.64 | 12.64 | 59.82 | 96.35 | 78.82 |
Book Value Per Share | 0.30 | 0.44 | 1.15 | 3.03 | 4.36 |
Tangible Book Value | 85.59 | 41.73 | 94.44 | 136.43 | 120.43 |
Tangible Book Value Per Share | 0.29 | 0.43 | 1.12 | 2.98 | 4.23 |
Machinery | 5.55 | 5.11 | 4.95 | 4.74 | 3.55 |